DSCAM-AS1 mediates pro-hypertrophy role of GRK2 in cardiac hypertrophy aggravation via absorbing miR-188-5p

[1]  Fenghua Wang,et al.  Long noncoding RNA MAGI1‐IT1 regulates cardiac hypertrophy by modulating miR‐302e/DKK1/Wnt/beta‐catenin signaling pathway , 2020, Journal of cellular physiology.

[2]  Q. Mao,et al.  LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis , 2019, Stem Cell Research & Therapy.

[3]  Ling-ling Jiang,et al.  Morin Inhibits Proliferation and Induces Apoptosis by Modulating the miR-188-5p/PTEN/AKT Regulatory Pathway in CML Cells , 2019, Molecular Cancer Therapeutics.

[4]  Xin-jian Lin,et al.  Aberrantly expressed miR-188-5p promotes gastric cancer metastasis by activating Wnt/β-catenin signaling , 2019, BMC Cancer.

[5]  Jing Li,et al.  Regulatory roles of long noncoding RNAs implicated in cancer hallmarks , 2019, International journal of cancer.

[6]  Xi Yang,et al.  p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma , 2019, Molecular Cancer.

[7]  Jianhong Lu,et al.  The role of exosomal noncoding RNAs in cancer , 2019, Molecular cancer.

[8]  Rui Xia,et al.  KLF5 and MYC modulated LINC00346 contributes to gastric cancer progression through acting as a competing endogeous RNA and indicates poor outcome , 2019, Cell Death & Differentiation.

[9]  N. Xie,et al.  Long noncoding RNA DSCAM-AS1 functions as an oncogene in non-small cell lung cancer by targeting BCL11A. , 2019, European review for medical and pharmacological sciences.

[10]  P. Xu,et al.  miR-188-5p regulates proliferation and invasion via PI3K/Akt/MMP-2/9 signaling in keloids , 2019, Acta biochimica et biophysica Sinica.

[11]  Geng Chen,et al.  LncRNA‐mRNA competing endogenous RNA network depicts transcriptional regulation in ischaemia reperfusion injury , 2019, Journal of cellular and molecular medicine.

[12]  Z. Zhong,et al.  Differential expression of circulating long non-coding RNAs in patients with acute myocardial infarction , 2018, Medicine.

[13]  W. Lei,et al.  Long noncoding RNA Meg3 regulates cardiomyocyte apoptosis in myocardial infarction , 2018, Gene Therapy.

[14]  Huanyu Li,et al.  LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3 , 2018, Molecular Cancer.

[15]  H. Shan,et al.  LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression , 2018, Molecular Cancer.

[16]  Z. Li,et al.  Long noncoding RNA myocardial infarction-associated transcript is associated with the microRNA-150-5p/P300 pathway in cardiac hypertrophy , 2018, International journal of molecular medicine.

[17]  Jun Tian,et al.  LncRNA myocardial infarction-associated transcript promotes cell proliferation and inhibits cell apoptosis by targeting miR-330-5p in epithelial ovarian cancer cells , 2018, Archives of medical science : AMS.

[18]  Jun Feng,et al.  lncRNA UCA1 Is a Novel Regulator in Cardiomyocyte Hypertrophy through Targeting the miR-184/HOXA9 Axis , 2018, Cardiorenal Medicine.

[19]  D. Liccardo,et al.  GRK2 as a therapeutic target for heart failure , 2018, Expert opinion on therapeutic targets.

[20]  Chaoqian Xu,et al.  The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214 , 2017, Molecular therapy. Nucleic acids.

[21]  Jianguo Shi,et al.  lncRNA ROR promotes the proliferation of renal cancer and is negatively associated with favorable prognosis. , 2017, Molecular medicine reports.

[22]  T. Wieland,et al.  G protein-coupled receptor kinase 2 promotes cardiac hypertrophy , 2017, PloS one.

[23]  Yanyan Ping,et al.  Oncogenic long noncoding RNA landscape in breast cancer , 2017, Molecular Cancer.

[24]  A. Chinnaiyan,et al.  The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression , 2016, Nature Communications.

[25]  Turan Tufan,et al.  MicroRNAs 29b and 181a down‐regulate the expression of the norepinephrine transporter and glucocorticoid receptors in PC12 cells , 2016, Journal of neurochemistry.

[26]  S. Oh,et al.  miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells , 2016, PloS one.

[27]  W. Koch,et al.  A peptide of the RGS domain of GRK2 binds and inhibits Gαq to suppress pathological cardiac hypertrophy and dysfunction , 2016, Science Signaling.

[28]  Dong I. Lee,et al.  Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy , 2016, Cardiovascular research.

[29]  W. Koch,et al.  GRK2 compromises cardiomyocyte mitochondrial function by diminishing fatty acid-mediated oxygen consumption and increasing superoxide levels. , 2015, Journal of molecular and cellular cardiology.

[30]  Dean P. Jones,et al.  Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial SIRT3 , 2015, Nature Communications.

[31]  W. Koch,et al.  Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction , 2015, Science Translational Medicine.

[32]  D. Parikh,et al.  Insulin induces IRS2-dependent and GRK2-mediated β2AR internalization to attenuate βAR signaling in cardiomyocytes. , 2015, Cellular signalling.

[33]  B. C. Bernardo,et al.  Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets , 2015, Archives of Toxicology.

[34]  Yuzhuo Wang,et al.  miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression , 2015, Oncotarget.

[35]  Chaoqian Xu,et al.  MicroRNA-328 as a regulator of cardiac hypertrophy. , 2014, International journal of cardiology.

[36]  P. Pandolfi,et al.  The multilayered complexity of ceRNA crosstalk and competition , 2014, Nature.

[37]  Pier Paolo Pandolfi,et al.  ceRNA cross-talk in cancer: when ce-bling rivalries go awry. , 2013, Cancer discovery.

[38]  D. Bartel,et al.  lincRNAs: Genomics, Evolution, and Mechanisms , 2013, Cell.

[39]  E. Olson,et al.  Cardiac hypertrophy: the good, the bad, and the ugly. , 2003, Annual review of physiology.

[40]  J. Higaki,et al.  Role of Cardiac Angiotensin II in Isoproterenol‐Induced Left Ventricular Hypertrophy , 1992, Hypertension.

[41]  A. Bosserhoff,et al.  Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts. , 2015, International journal of clinical and experimental pathology.